Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis.

Triana-Baltzer GB, Babizki M, Chan MC, Wong AC, Aschenbrenner LM, Campbell ER, Li QX, Chan RW, Peiris JS, Nicholls JM, Fang F.

J Antimicrob Chemother. 2010 Feb;65(2):275-84. doi: 10.1093/jac/dkp421. Epub 2009 Nov 26.

2.

Oseltamivir- and amantadine-resistant influenza viruses A (H1N1).

Cheng PK, Leung TW, Ho EC, Leung PC, Ng AY, Lai MY, Lim WW.

Emerg Infect Dis. 2009 Jun;15(6):966-8. doi: 10.3201/eid1506.081357.

3.

Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):521-4.

4.

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ.

Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225. Epub 2009 May 22.

5.

The signature features of influenza pandemics--implications for policy.

Miller MA, Viboud C, Balinska M, Simonsen L.

N Engl J Med. 2009 Jun 18;360(25):2595-8. doi: 10.1056/NEJMp0903906. Epub 2009 May 7. No abstract available. Erratum in: N Engl J Med. 2012 Feb 23;366(8):771.

6.

Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009.

Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde V, Garten RJ, Harris M, Gerber S, Vagasky S, Smith F, Pascoe N, Martin K, Dufficy D, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS, Finelli L.

N Engl J Med. 2009 Jun 18;360(25):2616-25. doi: 10.1056/NEJMoa0903812. Epub 2009 May 7. Erratum in: N Engl J Med. 2009 Jul 2;361(1):102.

7.

Implications of the emergence of a novel H1 influenza virus.

Belshe RB.

N Engl J Med. 2009 Jun 18;360(25):2667-8. doi: 10.1056/NEJMe0903995. Epub 2009 May 7. No abstract available.

8.

Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM.

N Engl J Med. 2009 Jun 18;360(25):2605-15. doi: 10.1056/NEJMoa0903810. Epub 2009 May 7. Erratum in: N Engl J Med. 2009 Jul 2;361(1):102.

9.

Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 May 1;58(16):433-5.

10.

Global transmission of oseltamivir-resistant influenza.

Moscona A.

N Engl J Med. 2009 Mar 5;360(10):953-6. doi: 10.1056/NEJMp0900648. Epub 2009 Mar 2. No abstract available.

11.

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St George K, Epperson S, Brammer L, Klimov AI, Bresee JS, Fry AM; Oseltamivir-Resistance Working Group.

JAMA. 2009 Mar 11;301(10):1034-41. doi: 10.1001/jama.2009.294. Epub 2009 Mar 2.

PMID:
19255110
12.

Developing new antiviral agents for influenza treatment: what does the future hold?

Hayden F.

Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13. doi: 10.1086/591851. Review.

13.

Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity.

Stevens J, Blixt O, Chen LM, Donis RO, Paulson JC, Wilson IA.

J Mol Biol. 2008 Sep 19;381(5):1382-94. doi: 10.1016/j.jmb.2008.04.016. Epub 2008 Apr 11.

14.

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. doi: 10.1128/AAC.00555-08. Epub 2008 Jul 14.

15.

Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses.

Chen LM, Davis CT, Zhou H, Cox NJ, Donis RO.

PLoS Pathog. 2008 May 23;4(5):e1000072. doi: 10.1371/journal.ppat.1000072.

16.

Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918.

Nelson MI, Viboud C, Simonsen L, Bennett RT, Griesemer SB, St George K, Taylor J, Spiro DJ, Sengamalay NA, Ghedin E, Taubenberger JK, Holmes EC.

PLoS Pathog. 2008 Feb 29;4(2):e1000012. doi: 10.1371/journal.ppat.1000012.

17.

Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households.

Cowling BJ, Fung RO, Cheng CK, Fang VJ, Chan KH, Seto WH, Yung R, Chiu B, Lee P, Uyeki TM, Houck PM, Peiris JS, Leung GM.

PLoS One. 2008 May 7;3(5):e2101. doi: 10.1371/journal.pone.0002101.

18.

Comment on: concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza.

Nicholls JM, Aschenbrenner LM, Paulson JC, Campbell ER, Malakhov MP, Wurtman DF, Yu M, Fang F.

J Antimicrob Chemother. 2008 Aug;62(2):426-8; author reply 428-9. doi: 10.1093/jac/dkn167. Epub 2008 Apr 22. No abstract available.

19.

Comparison of nasopharyngeal flocked swabs and aspirates for rapid diagnosis of respiratory viruses in children.

Chan KH, Peiris JS, Lim W, Nicholls JM, Chiu SS.

J Clin Virol. 2008 May;42(1):65-9. doi: 10.1016/j.jcv.2007.12.003. Epub 2008 Feb 1.

PMID:
18242124
20.

Update on avian influenza A (H5N1) virus infection in humans.

Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, Naghdaliyev A, Peiris JS, Shindo N, Soeroso S, Uyeki TM.

N Engl J Med. 2008 Jan 17;358(3):261-73. doi: 10.1056/NEJMra0707279. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk